Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, September 13, 2018
CytRx has received a milestone payment of $250,000 from Orphazyme A/S.
read more
Friday, November 01, 2019
Atlanta is now Dachser's fourth location to receive certification in ten months, further expanding the company's network services for its customers in the life science and healthcare sector.
read more
Following Frankfurt, Atlanta, Mumbai, and Hyderabad, Shanghai is now Dachser’s fifth location to receive a CEIV certification, further expanding the company’s network services for its customers in the life science and healthcare (LSH) sector.
...
read more
Thursday, October 14, 2021
The Department of Air Force, in coordination with the Department of Health and Human Services (HHS), awarded a $30 million contract to Eurofins Genomics US to build a new production facility and expanded capacity for the manufacturing of reagents ...
read more
Wednesday, October 12, 2016
Daiichi Sankyo Company, Limited and the Dana-Farber Cancer Institute have announced a preclinical research collaboration focused on lung cancer.
read more
Wednesday, October 26, 2016
Daiichi Sankyo, Inc. and Inspirion Delivery Sciences LLC (Inspirion) announced today that the companies have entered into a strategic collaboration agreement in the U.S. to commercialize FDA-approved MorphaBond™ (morphine sulfate) extended-release ...
read more
Daiichi Sankyo and Glycotope GmbH have entered into an exclusive worldwide licensing agreement to develop an ADC.
read more
Daiichi Sankyo Company and Boston Pharmaceuticals, Inc. have entered into a worldwide licensing agreement for Daiichi Sankyo's novel RET inhibitor, DS-5010.
read more
Berkeley Lights announced a program with global pharmaceutical company Daiichi Sankyo focused on using the Beacon platform to accelerate its cell line development workflow.
read more
The companies are coming together to form a coalition to accomplish their shared goal of bringing promising cancer therapies to patients.
read more
Wednesday, December 15, 2021
Gamma Biosciences, a global life sciences company serving the academic and advanced therapy market, announced the appointment of Dale Gordon as Chief Executive Officer (CEO) of its operating company Mirus Bio. Gordon succeeds founders Jon Wolff and ...
read more
Tuesday, January 17, 2017
Dalton Pharma Services has announced the signing of a drug development and manufacturing services agreement with Cerium Pharmaceuticals, Inc., an emerging biopharmaceutical company based in Gaithersburg, Maryland, USA. Cerium is dedicated to the ...
read more
Dalton Pharma Services has declared the signing of a drug development and manufacturing services agreement with Oryn Therapeutics, an American biotechnology firm.
read more
Dalton Pharma Services announced the signing of a drug development and manufacturing services agreement with Arch Biopartners.
read more
Dalton Pharma Services has announced the signing of a drug development and manufacturing services agreement with Oryn Therapeutics.
read more